Cargando…
Publisher Correction: Reply to: How many SARS-CoV-2 “viroporins” are really ion channels?
Autores principales: | Toft-Bertelsen, Trine L., Jeppesen, Mads Gravers, Landbrug, Asante, Mujezinovic, Amer, Bentzen, Bo Hjorth, Kledal, Thomas Nitschke, Rosenkilde, Mette Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514189/ https://www.ncbi.nlm.nih.gov/pubmed/36168041 http://dx.doi.org/10.1038/s42003-022-03982-w |
Ejemplares similares
-
Reply to: How Many SARS-CoV-2 “Viroporins” Are Really Ion Channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022) -
Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
por: Toft-Bertelsen, Trine Lisberg, et al.
Publicado: (2021) -
Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
por: Toft-Bertelsen, Trine Lisberg, et al.
Publicado: (2021) -
How many SARS-CoV-2 “viroporins” are really ion channels?
por: Harrison, Neil L., et al.
Publicado: (2022) -
Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1
por: Knerr, Julius Maximilian, et al.
Publicado: (2021)